இல் விட்ரோ பெருங்குடல் புற்றுநோய் திரையிடல் சோதனைகள் சந்தை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

33 In-vitro colorectal cancer screening tests market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to reach at USD 1316.7 million and at a growth rate CAGR of 6.40% in the above-mentioned forecast period. Introduction of novel screening tests employing genetic testing, growing incidence of rectal and colon cancer are some factors driving the growth of the market. The major players covered in the in-vitro colorectal cancer screening tests market report are  Abbott, Clinical Genomics Technologies Pty, Ltd, Epigenomics Inc, Hemosure, Inc, Exact Sciences Corporation, NOVIGENIX SA, Sekisui Diagnostics, Medline Industries, Inc, Beckman Coulter, Inc, Eiken Chemical Co, Ltd, Sysmex Corporation, Siemens Healthcare Private Limited, Quest Diagnostics Incorporated, Oncocyte, Merck KGaA, Immunostics Inc, ExiQon, Kyowa Electronic Instruments Co. Ltd, R-Biopharm AG among other domestic and global players

Hong kongUnited kingdomClinical genomics technologies pty ltdQuest diagnostics incorporatedSysmex corporationTechnology penetrationMerck kgaSiemens healthcare privateHemosure incEiken chemical co ltdMarket developmentEpigenomics incMedline industries incMarket researchKyowa electronic instruments coMerck kgaa